Highly Variable Biodistribution of 68Ga Labeled Somatostatin Analogue DOTA-NOC/TATE in Neuroendocrine Tumors: Clinical Implications for Somatostatin Receptor Directed PET/CT

被引：0
|
作者：
Cheng, Monica [1 ]
Tann, Mark [2 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1019
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Reduction of [68Ga]Ga-DOTA-TATE injected activity for digital PET/MR in comparison with analogue PET/CT
    Cox, Christina P. W.
    Brabander, Tessa
    Vegt, Erik
    de la Sabloniere, Quido G. de Lussanet
    Graven, Laura H.
    Verburg, Frederik A.
    Segbers, Marcel
    EJNMMI PHYSICS, 2024, 11 (01)
  • [32] In Vivo Visualization of Somatostatin Receptor Expression With Ga-68-DOTA-TATE PET/CT in Advanced Metastatic Prostate Cancer
    Alonso, Omar
    Gambini, Juan P.
    Lago, Graciela
    Gaudiano, Javier
    Quagliata, Adriana
    Engler, Henry
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (11) : 1063 - 1064
  • [33] Oncogenic osteomalacia: Role of 68Ga DOTA-NOC PET/CT scan in identifying the culprit lesion and its management
    Gambhir, S.
    Singh, D.
    Ravina, M.
    Barai, S.
    Prashanth, A.
    Kumar, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S655 - S655
  • [34] The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors
    Fuad Novruzov
    Aziz Aliyev
    Ming Young S. Wan
    Rizwan Syed
    Elnur Mehdi
    Irada Aliyeva
    Francesco Giammarile
    Jamshed B. Bomanji
    Irfan Kayani
    European Journal of Hybrid Imaging, 5
  • [35] The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors
    Novruzov, Fuad
    Aliyev, Aziz
    Wan, Ming Young S.
    Syed, Rizwan
    Mehdi, Elnur
    Aliyeva, Irada
    Giammarile, Francesco
    Bomanji, Jamshed B.
    Kayani, Irfan
    EUROPEAN JOURNAL OF HYBRID IMAGING, 2021, 5 (01):
  • [36] Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
    Martin H. Cherk
    Grace Kong
    Rodney J. Hicks
    Michael S. Hofman
    Cancer Imaging, 18
  • [37] Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
    Cherk, Martin H.
    Kong, Grace
    Hicks, Rodney J.
    Hofman, Michael S.
    CANCER IMAGING, 2018, 18
  • [38] Beyond 68Ga-labeled somatostatin analogues: is it time to say goodbye to [68Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?
    Gaia Ninatti
    Paola Mapelli
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2246 - 2247
  • [39] Beyond 68Ga-labeled somatostatin analogues: is it time to say goodbye to [68Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?
    Ninatti, Gaia
    Mapelli, Paola
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2246 - 2247
  • [40] Utility of 68Ga DOTA-Octreotate PET/CT in Characterization of Pediatric Neuroendocrine Tumors
    McKone, E. L.
    Kowalchuk, R. O.
    Dorr, M.
    Cameron, J. D.
    Connors, M. A.
    Allen-Rhoades, W.
    Schoettler, P. J.
    Rawwas, J.
    Johnson, D. R.
    Johnson, G. B.
    Mahajan, A.
    Ahmed, S. K.
    Laack, N. N., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E704 - E705
12345